LGP
LITTLEGRN FPO [LGP]
Healthcare · ASX Small Cap
$0.1100 +4.8%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +7First seen: 2026-02-25
Score Breakdown
Technical48
Catalyst56
Sentiment50
Fundamental85
Momentum57
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic bullish crossover (from low)
- Adequate cash runway (6 quarters)
- 4C filed 2026-01-29
- Low P/S ratio (0.8x)
- Moderate revenue growth (+9%)
- EPS estimates revised downward (-10pts)
- Near 52-week low (15% of range)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (19%)
- Healthy profit margins (15%)
- Analyst EPS expectations falling (-85%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Negative 5-day momentum (-4.3%)
- Below 200-day MA (long-term downtrend)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Change of Directors Interest Notice x2
NONE Application for quotation of securities - LGP
NONE Proposed sale of WA production facility
HIGH Investor Presentation - Proposed Merger
LOW Quarterly Activities Report and Appendix 4C
Announcement tone +3pts
Recent ASX Announcements
| 2026-02-26 | Change of Directors Interest Notice x2 |
| 2026-02-26 | Application for quotation of securities - LGP |
| 2026-02-18 | Proposed sale of WA production facility PRICE SENSITIVE |
| 2026-02-02 | Investor Presentation - Proposed Merger |
| 2026-01-29 | Quarterly Activities Report and Appendix 4C PRICE SENSITIVE |
Key Metrics
$32.1M
Market Cap
133K
Avg Volume
1.2x
Vol Ratio
$0.10 — $0.14
52-Week Range
N/A
Short Interest
6 qtrs
Cash Runway
7.4%
ROE
15.2%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | neutral | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 75% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | pass | Inst: 19% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #39 of 119 · Sector avg: 51
View all Healthcare signals →